OncoSec Medical Inc logo

ONCS - OncoSec Medical Inc Share Price

$1.96 -0.0  -0.5%

Last Trade - 9:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £36.0m
Enterprise Value £12.9m
Revenue £n/a
Position in Universe 4708th / 6348
Bullish
Bearish
Unlock ONCS Revenue
Momentum
Relative Strength (%)
1m -9.52%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jul 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 0.94
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 April 2020, OncoSec Medical Inc revenues was not reported. Net loss increased 46% to $33.3M. Higher net loss reflects General and administrative - Balancing v increase of 95% to $14.7M (expense), Research and development - Balancing val increase of 29% to $16.8M (expense), Other income decrease of 45% to $182K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ONCS Revenue Unlock ONCS Revenue

Net Income

ONCS Net Income Unlock ONCS Revenue

Normalised EPS

ONCS Normalised EPS Unlock ONCS Revenue

PE Ratio Range

ONCS PE Ratio Range Unlock ONCS Revenue

Dividend Yield Range

ONCS Dividend Yield Range Unlock ONCS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ONCS EPS Forecasts Unlock ONCS Revenue
Profile Summary

OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company’s core platform technology, ImmunoPulse, is a drug-device therapeutic modality comprised of intratumoral electroporation (EP) delivery device. The ImmunoPulse platform is designed to deliver plasmid deoxyribonucleic acid (DNA)-encoded drugs directly into a solid tumor and promote an immunological response against cancer. The ImmunoPulse device can be adapted to treat different tumor types and consists of an electrical pulse generator, a reusable handle and disposable applicators. The Company’s lead product candidate is a DNA-encoded interleukin-12 (IL-12) called tavokinogene telseplasmid (TAVO).

Directors
Last Annual July 31st, 2019
Last Interim April 30th, 2020
Incorporated February 8, 2008
Public Since May 29, 2015
No. of Shareholders: 45
No. of Employees: 37
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 23,031,866
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ONCS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ONCS
Upcoming Events for ONCS
Frequently Asked Questions for OncoSec Medical Inc
What is the OncoSec Medical Inc share price?

As of 9:00pm, shares in OncoSec Medical Inc are trading at $1.96, giving the company a market capitalisation of £36.0m. This share price information is delayed by 15 minutes.

How has the OncoSec Medical Inc share price performed this year?

Shares in OncoSec Medical Inc are currently trading at $1.96 and the price has moved by -6.64% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the OncoSec Medical Inc price has moved by -11.15% over the past year.

What are the analyst and broker recommendations for OncoSec Medical Inc?

Of the analysts with advisory recommendations for OncoSec Medical Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for OncoSec Medical Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will OncoSec Medical Inc next release its financial results?

OncoSec Medical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-04-30
What is the OncoSec Medical Inc dividend yield?

OncoSec Medical Inc does not currently pay a dividend.

Does OncoSec Medical Inc pay a dividend?

OncoSec Medical Inc does not currently pay a dividend.

When does OncoSec Medical Inc next pay dividends?

OncoSec Medical Inc does not currently pay a dividend.

How do I buy OncoSec Medical Inc shares?

To buy shares in OncoSec Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of OncoSec Medical Inc?

Shares in OncoSec Medical Inc are currently trading at $1.96, giving the company a market capitalisation of £36.0m.

Where are OncoSec Medical Inc shares listed? Where are OncoSec Medical Inc shares listed?

Here are the trading details for OncoSec Medical Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: ONCS
What kind of share is OncoSec Medical Inc?

Based on an overall assessment of its quality, value and momentum, OncoSec Medical Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a OncoSec Medical Inc share price forecast 2020?

Shares in OncoSec Medical Inc are currently priced at $1.96. At that level they are trading at 0.272% discount to the analyst consensus target price of 0.00.

Analysts covering OncoSec Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.41 for the next financial year.

How can I tell whether the OncoSec Medical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OncoSec Medical Inc. Over the past six months, the relative strength of its shares against the market has been 4.01%. At the current price of $1.96, shares in OncoSec Medical Inc are trading at 3.52% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the OncoSec Medical Inc PE Ratio?

We were not able to find PE ratio data for OncoSec Medical Inc.

Who are the key directors of OncoSec Medical Inc?

OncoSec Medical Inc's management team is headed by:

Daniel O'Connor - PRE
Joon Kim - DRC
Margaret Dalesandro - DRC
Robert DelAversano - CAO
Yuhang Zhao - DRC
Kevin Smith - DRC
Herbert Lyerly - DRC
Who are the major shareholders of OncoSec Medical Inc?

Here are the top five shareholders of OncoSec Medical Inc based on the size of their shareholding:

China Grand Pharmaceutical and Healthcare Holdings, Ltd. Corporation
Percentage owned: 52.1% (12.0m shares)
Alpha Holdings Inc Corporation
Percentage owned: 6.99% (1.61m shares)
Armistice Capital LLC Hedge Fund
Percentage owned: 2.39% (550k shares)
Altium Capital Management LP Investment Advisor/Hedge Fund
Percentage owned: 2.11% (486k shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 1.03% (238k shares)
Similar to ONCS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.